MILANO, SERENA
 Distribuzione geografica
Continente #
NA - Nord America 1.636
EU - Europa 426
AS - Asia 151
AF - Africa 1
SA - Sud America 1
Totale 2.215
Nazione #
US - Stati Uniti d'America 1.636
IT - Italia 192
CN - Cina 127
SE - Svezia 108
UA - Ucraina 28
FR - Francia 20
DE - Germania 19
GB - Regno Unito 19
FI - Finlandia 18
IN - India 11
RO - Romania 6
VN - Vietnam 5
BE - Belgio 4
IE - Irlanda 4
CZ - Repubblica Ceca 3
IR - Iran 2
TW - Taiwan 2
AT - Austria 1
BD - Bangladesh 1
BG - Bulgaria 1
CL - Cile 1
ES - Italia 1
GR - Grecia 1
KG - Kirghizistan 1
MA - Marocco 1
RU - Federazione Russa 1
SG - Singapore 1
TR - Turchia 1
Totale 2.215
Città #
Fairfield 240
Chandler 201
Woodbridge 143
Seattle 116
Ashburn 110
Houston 101
Nyköping 97
Cambridge 90
Wilmington 85
Bari 62
Jacksonville 60
New York 51
Beijing 39
Ann Arbor 36
Roxbury 29
Nanjing 28
Lawrence 27
Dearborn 23
Des Moines 18
Inglewood 17
San Diego 15
Princeton 14
Nanchang 12
Shenyang 10
Adelfia 9
Boardman 9
Brasov 6
Como 6
Hebei 6
Pune 6
Taranto 6
Brooklyn 5
Foggia 5
Hefei 5
Brussels 4
Catania 4
Dong Ket 4
Dublin 4
Kunming 4
Redwood City 4
Agrigento 3
Faenza 3
Jinan 3
London 3
Rome 3
San Mateo 3
Stimigliano 3
Atlanta 2
Augusta 2
Baotou 2
Changsha 2
Frattaminore 2
Guangzhou 2
Hangzhou 2
Hounslow 2
Indiana 2
Jiaxing 2
Kilburn 2
Marseille 2
Monmouth Junction 2
Montorso Vicentino 2
Mountain View 2
Naples 2
Napoli 2
Norwalk 2
Paris 2
San Francisco 2
Shanghai 2
Taipei 2
Tappahannock 2
Tianjin 2
Treviso 2
Turin 2
Ardabil 1
Bielefeld 1
Bremen 1
Brno 1
Canzo 1
Casarano 1
Casoria 1
Castel San Giorgio 1
Centro 1
Chengdu 1
Chiswick 1
Chongqing 1
Colleferro 1
Craco 1
Edinburgh 1
Frankfurt am Main 1
Fuzhou 1
Gioia del Colle 1
Haikou 1
Hanoi 1
Kayseri 1
Kemerovo 1
Leawood 1
Lentini 1
Los Angeles 1
Madrid 1
Malgrate 1
Totale 1.811
Nome #
STATINE E SECRETINA COME NUOVO APPROCCIO TERAPEUTICO PER I PAZIENTI AFFETTI DA DIABETE INSIPIDO NEFROGENICO 128
Functional study of a KCNH2 mutant: Novel insights on the pathogenesis of the LQT2 syndrome 118
Fluvastatin Increases AQP2 Urine Excretion in a Dyslipidemic Patient with Nephrogenic Diabetes Insipidus: An In Vivo and In Vitro Study 115
Hereditary Nephrogenic Diabetes Insipidus: Molecular Basis of the Defect and Potential Novel Strategies for Treatment 114
AQP1-Containing Exosomes in Peritoneal Dialysis Effluent As Biomarker of Dialysis Efficiency 107
Rosiglitazone promotes AQP2 plasma membrane expression in renal cells via a ca-dependent/cAMP-independent mechanism 106
Fluvastatin modulates renal water reabsorption in vivo through increased AQP2 availability at the apical plasma membrane of collecting duct cells 96
Spilanthol from Acmella oleracea lowers the intracellular levels of cAMP impairing NKCC2 phosphorylation and water channel AQP2 membrane expression in mouse kidney 90
null 86
β3 adrenergic receptor in the kidney may be a new player in sympathetic regulation of renal function 86
Co-regulated pendrin and aquaporin 5 expression and trafficking in Type-B intercalated cells under potassium depletion. 86
Data on the influence of inorganic clays to improve mechanical and healing properties of antibacterial Gellan gum-Manuka honey hydrogels 79
null 77
Hereditary nephrogenic diabetes insipidus: Pathophysiology and possible treatment. An update 76
Reply to the Letter to the Editor entitled "Response to Statins in the Prevention of Lithium-Associated Diabetes Insipidus: Preliminary Findings" 75
Advances in cartilage repair: The influence of inorganic clays to improve mechanical and healing properties of antibacterial Gellan gum-Manuka honey hydrogels 70
null 69
null 64
null 63
null 52
A novel treatment for X-linked nephrogenic diabetes insipidus: the secret in secretin? 47
Role of PKC in the Regulation of the Human Kidney Chloride Channel ClC-Ka 47
Rosiglitazone increases aquaporin 2 transcription and apical expression in renal cells: possible implication for treating nephrogenic diabetes insipidus? 44
Statins as potential therapeutic agents for handling Nephrogenic Diabetes Insipidus 44
Rosiglitazone promotes AQP-2 translocation in renal cells via a Ca2+ dependent/cAMP independent mechanism (892.9) 42
null 37
Aquaporin-1 facilitates transmesothelial water permeability: In vitro and ex vivo evidence and possible implications in peritoneal dialysis 35
Pro-inflammatory cytokines as emerging molecular determinants in cardiolaminopathies 33
Activation of the Thiazide-Sensitive Sodium-Chloride Cotransporter by Beta3-Adrenoreceptor in the Distal Convoluted Tubule 30
Hypercholesterolemic patients display a statin-dependent increase of urinary aquaporin 2 (uAQP2) excretion. An additional pleiotropic effect and a potential biomarker of statins efficacy? 26
Human β3-Adrenoreceptor is Resistant to Agonist-Induced Desensitization in Renal Epithelial Cells 26
Statins increase AQP2 urinary excretion in hypercholesterolemic patients: a pleiotropic effect of statins of potential interest for patients with defects of AQP2 trafficking. 25
Functional Characterization of a Novel Truncating Mutation in Lamin A/C Gene in a Family with a Severe Cardiomyopathy with Conduction Defects 25
Aptamer Grafting onto (on) and into (in) Pegylated Gold Nanoparticles: Physicochemical Characterization and In vitro Cytotoxicity Investigation in Renal Cells. 23
Mu opioid receptor in spermatozoa, eggs and larvae of gilthead sea bream (Sparus Aurata) and its involvement in stress related to aquaculture 21
TRPML1-Induced Lysosomal Ca2+ Signals Activate AQP2 Translocation and Water Flux in Renal Collecting Duct Cells 11
B3 Adrenergic Receptor Agonist Mirabegron Increases AQP2 and NKCC2 Urinary Excretion in OAB Patients: A Pleiotropic Effect of Interest for Patients with X-Linked Nephrogenic Diabetes Insipidus 9
Role of Nuclear Lamin A/C in the Regulation of Nav1.5 Channel and Microtubules: Lesson From the Pathogenic Lamin A/C Variant Q517X 8
null 7
Pushing forward Gellan gum-based hydrogels: the impact of inorganic fillers on mechanical and biological performances 5
Combination of secretin and fluvastatin ameliorates the polyuria associated with X-linked nephrogenic diabetes insipidus in mice. 5
The β-adrenoceptor agonist isoproterenol promotes the activity of respiratory chain complex I and lowers cellular reactive oxygen species in fibroblasts and heart myoblasts 4
β3-Adrenoceptor as a new player in the sympathetic regulation of the renal acid-base homeostasis 2
Totale 2.313
Categoria #
all - tutte 9.016
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.016


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201981 0 0 0 0 0 0 0 0 0 0 41 40
2019/2020661 59 22 21 47 72 59 99 78 80 44 54 26
2020/2021372 24 20 23 29 40 34 39 29 35 44 30 25
2021/2022274 15 16 2 8 7 28 6 14 35 34 40 69
2022/2023523 49 58 36 57 49 82 7 58 94 5 15 13
2023/2024219 13 36 5 32 17 81 6 10 8 11 0 0
Totale 2.313